carbostyril and agar
carbostyril has been researched along with agar in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Erwin, ME; Jones, RN | 1 |
| De Zutter, L; Okerman, L; Van Hende, J | 1 |
| Changkwanyeun, R; Matsumoto, M; Nakajima, C; Oka, D; Suzuki, Y; Yamaguchi, T | 1 |
| Nakaminami, H; Tanaka, E; Uchiya, KI; Wajima, T | 1 |
Other Studies
4 other study(ies) available for carbostyril and agar
| Article | Year |
|---|---|
Interpretive criteria for susceptibility testing of CI-960 (PD127391, AM-1091), fleroxacin, lomefloxacin, and temafloxacin against Neisseria gonorrhoeae, including drug stability in GC agar medium.
Topics: Agar; Anti-Infective Agents; Drug Stability; Fleroxacin; Fluoroquinolones; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Quinolones | 1992 |
Stability of frozen stock solutions of beta-lactam antibiotics, cephalosporins, tetracyclines and quinolones used in antibiotic residue screening and antibiotic susceptibility testing.
Topics: Agar; Amoxicillin; Bacillus subtilis; beta-Lactams; Cephalosporins; Chemistry Techniques, Analytical; Drug Residues; Hydrogen-Ion Concentration; Methanol; Quinolones; Temperature; Tetracyclines; Time Factors | 2007 |
In vitro antibacterial activity of OPS-2071 against Gram-positive and Gram-negative enteropathogenic bacteria.
Topics: Agar; Anti-Bacterial Agents; DNA Gyrase; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Staphylococcus aureus; Topoisomerase II Inhibitors | 2022 |
Contribution of amino acid substitutions in ParE to quinolone resistance in Haemophilus haemolyticus revealed through a horizontal transfer assay using Haemophilus influenzae.
Topics: Agar; Amino Acid Substitution; Anti-Bacterial Agents; Child; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Quinolones | 2023 |